 | • レポートコード：MRC2-11QY04679 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は軟組織同種移植のグローバル市場について調査・分析したレポートです。種類別（ヒアリン、エラスティック、フィブロ）市場規模、用途別（病院、外来外科センター、歯科医院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別軟組織同種移植の競争状況、市場シェア ・世界の軟組織同種移植市場：種類別市場規模 2015年-2020年（ヒアリン、エラスティック、フィブロ） ・世界の軟組織同種移植市場：種類別市場規模予測 2021年-2026年（ヒアリン、エラスティック、フィブロ） ・世界の軟組織同種移植市場：用途別市場規模 2015年-2020年（病院、外来外科センター、歯科医院） ・世界の軟組織同種移植市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、歯科医院） ・北米の軟組織同種移植市場分析：米国、カナダ ・ヨーロッパの軟組織同種移植市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの軟組織同種移植市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の軟組織同種移植市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの軟組織同種移植市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、B. Braun Melsungen、CONMED、Xtant Medical Holdings、Alliqua BioMedical、ALON SOURCE GROUP、AlloSource、C. R. Bard、Arthrex、Bone Bank Allografts、Osiris Therapeutics、MiMedx Group、Integra LifeSciences、Organogenesis、RTI Surgical、Lattice Biologics、Globus Medical、Zimmer Biomet Holdings、Straumann Holding ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Soft tissue refers to human skin, subcutaneous tissue, muscle, tendon, ligament, joint capsule, synovial capsule, nerve, blood vessel, etc.
Increasing prevalence of degenerative joint diseases and high definition designed technology are the major drivers of the global soft tissue allografts market.
Market Analysis and Insights: Global Soft Tissue Allografts Market
The global Soft Tissue Allografts market size is projected to reach US$ 2957.2 million by 2026, from US$ 2800 million in 2020, at a CAGR of 5.2%% during 2021-2026.
Global Soft Tissue Allografts Scope and Market Size
Soft Tissue Allografts market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Soft Tissue Allografts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Allergan
B. Braun Melsungen
CONMED
Xtant Medical Holdings
Alliqua BioMedical
ALON SOURCE GROUP
AlloSource
C. R. Bard
Arthrex
Bone Bank Allografts
Osiris Therapeutics
MiMedx Group
Integra LifeSciences
Organogenesis
RTI Surgical
Lattice Biologics
Globus Medical
Zimmer Biomet Holdings
Straumann Holding
Market segment by Type, the product can be split into
Hyaline
Elastic
Fibro
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Dental Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Soft Tissue Allografts Revenue
1.4 Market by Type
1.4.1 Global Soft Tissue Allografts Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hyaline
1.4.3 Elastic
1.4.4 Fibro
1.5 Market by Application
1.5.1 Global Soft Tissue Allografts Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Dental Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Soft Tissue Allografts Market Perspective (2015-2026)
2.2 Global Soft Tissue Allografts Growth Trends by Regions
2.2.1 Soft Tissue Allografts Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Soft Tissue Allografts Historic Market Share by Regions (2015-2020)
2.2.3 Soft Tissue Allografts Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Soft Tissue Allografts Market Growth Strategy
2.3.6 Primary Interviews with Key Soft Tissue Allografts Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Soft Tissue Allografts Players by Market Size
3.1.1 Global Top Soft Tissue Allografts Players by Revenue (2015-2020)
3.1.2 Global Soft Tissue Allografts Revenue Market Share by Players (2015-2020)
3.1.3 Global Soft Tissue Allografts Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Soft Tissue Allografts Market Concentration Ratio
3.2.1 Global Soft Tissue Allografts Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Soft Tissue Allografts Revenue in 2019
3.3 Soft Tissue Allografts Key Players Head office and Area Served
3.4 Key Players Soft Tissue Allografts Product Solution and Service
3.5 Date of Enter into Soft Tissue Allografts Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Soft Tissue Allografts Historic Market Size by Type (2015-2020)
4.2 Global Soft Tissue Allografts Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Soft Tissue Allografts Market Size by Application (2015-2020)
5.2 Global Soft Tissue Allografts Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Soft Tissue Allografts Market Size (2015-2020)
6.2 Soft Tissue Allografts Key Players in North America (2019-2020)
6.3 North America Soft Tissue Allografts Market Size by Type (2015-2020)
6.4 North America Soft Tissue Allografts Market Size by Application (2015-2020)
7 Europe
7.1 Europe Soft Tissue Allografts Market Size (2015-2020)
7.2 Soft Tissue Allografts Key Players in Europe (2019-2020)
7.3 Europe Soft Tissue Allografts Market Size by Type (2015-2020)
7.4 Europe Soft Tissue Allografts Market Size by Application (2015-2020)
8 China
8.1 China Soft Tissue Allografts Market Size (2015-2020)
8.2 Soft Tissue Allografts Key Players in China (2019-2020)
8.3 China Soft Tissue Allografts Market Size by Type (2015-2020)
8.4 China Soft Tissue Allografts Market Size by Application (2015-2020)
9 Japan
9.1 Japan Soft Tissue Allografts Market Size (2015-2020)
9.2 Soft Tissue Allografts Key Players in Japan (2019-2020)
9.3 Japan Soft Tissue Allografts Market Size by Type (2015-2020)
9.4 Japan Soft Tissue Allografts Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Soft Tissue Allografts Market Size (2015-2020)
10.2 Soft Tissue Allografts Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Soft Tissue Allografts Market Size by Type (2015-2020)
10.4 Southeast Asia Soft Tissue Allografts Market Size by Application (2015-2020)
11 India
11.1 India Soft Tissue Allografts Market Size (2015-2020)
11.2 Soft Tissue Allografts Key Players in India (2019-2020)
11.3 India Soft Tissue Allografts Market Size by Type (2015-2020)
11.4 India Soft Tissue Allografts Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Soft Tissue Allografts Market Size (2015-2020)
12.2 Soft Tissue Allografts Key Players in Central & South America (2019-2020)
12.3 Central & South America Soft Tissue Allografts Market Size by Type (2015-2020)
12.4 Central & South America Soft Tissue Allografts Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Soft Tissue Allografts Introduction
13.1.4 Allergan Revenue in Soft Tissue Allografts Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 B. Braun Melsungen
13.2.1 B. Braun Melsungen Company Details
13.2.2 B. Braun Melsungen Business Overview
13.2.3 B. Braun Melsungen Soft Tissue Allografts Introduction
13.2.4 B. Braun Melsungen Revenue in Soft Tissue Allografts Business (2015-2020)
13.2.5 B. Braun Melsungen Recent Development
13.3 CONMED
13.3.1 CONMED Company Details
13.3.2 CONMED Business Overview
13.3.3 CONMED Soft Tissue Allografts Introduction
13.3.4 CONMED Revenue in Soft Tissue Allografts Business (2015-2020)
13.3.5 CONMED Recent Development
13.4 Xtant Medical Holdings
13.4.1 Xtant Medical Holdings Company Details
13.4.2 Xtant Medical Holdings Business Overview
13.4.3 Xtant Medical Holdings Soft Tissue Allografts Introduction
13.4.4 Xtant Medical Holdings Revenue in Soft Tissue Allografts Business (2015-2020)
13.4.5 Xtant Medical Holdings Recent Development
13.5 Alliqua BioMedical
13.5.1 Alliqua BioMedical Company Details
13.5.2 Alliqua BioMedical Business Overview
13.5.3 Alliqua BioMedical Soft Tissue Allografts Introduction
13.5.4 Alliqua BioMedical Revenue in Soft Tissue Allografts Business (2015-2020)
13.5.5 Alliqua BioMedical Recent Development
13.6 ALON SOURCE GROUP
13.6.1 ALON SOURCE GROUP Company Details
13.6.2 ALON SOURCE GROUP Business Overview
13.6.3 ALON SOURCE GROUP Soft Tissue Allografts Introduction
13.6.4 ALON SOURCE GROUP Revenue in Soft Tissue Allografts Business (2015-2020)
13.6.5 ALON SOURCE GROUP Recent Development
13.7 AlloSource
13.7.1 AlloSource Company Details
13.7.2 AlloSource Business Overview
13.7.3 AlloSource Soft Tissue Allografts Introduction
13.7.4 AlloSource Revenue in Soft Tissue Allografts Business (2015-2020)
13.7.5 AlloSource Recent Development
13.8 C. R. Bard
13.8.1 C. R. Bard Company Details
13.8.2 C. R. Bard Business Overview
13.8.3 C. R. Bard Soft Tissue Allografts Introduction
13.8.4 C. R. Bard Revenue in Soft Tissue Allografts Business (2015-2020)
13.8.5 C. R. Bard Recent Development
13.9 Arthrex
13.9.1 Arthrex Company Details
13.9.2 Arthrex Business Overview
13.9.3 Arthrex Soft Tissue Allografts Introduction
13.9.4 Arthrex Revenue in Soft Tissue Allografts Business (2015-2020)
13.9.5 Arthrex Recent Development
13.10 Bone Bank Allografts
13.10.1 Bone Bank Allografts Company Details
13.10.2 Bone Bank Allografts Business Overview
13.10.3 Bone Bank Allografts Soft Tissue Allografts Introduction
13.10.4 Bone Bank Allografts Revenue in Soft Tissue Allografts Business (2015-2020)
13.10.5 Bone Bank Allografts Recent Development
13.11 Osiris Therapeutics
10.11.1 Osiris Therapeutics Company Details
10.11.2 Osiris Therapeutics Business Overview
10.11.3 Osiris Therapeutics Soft Tissue Allografts Introduction
10.11.4 Osiris Therapeutics Revenue in Soft Tissue Allografts Business (2015-2020)
10.11.5 Osiris Therapeutics Recent Development
13.12 MiMedx Group
10.12.1 MiMedx Group Company Details
10.12.2 MiMedx Group Business Overview
10.12.3 MiMedx Group Soft Tissue Allografts Introduction
10.12.4 MiMedx Group Revenue in Soft Tissue Allografts Business (2015-2020)
10.12.5 MiMedx Group Recent Development
13.13 Integra LifeSciences
10.13.1 Integra LifeSciences Company Details
10.13.2 Integra LifeSciences Business Overview
10.13.3 Integra LifeSciences Soft Tissue Allografts Introduction
10.13.4 Integra LifeSciences Revenue in Soft Tissue Allografts Business (2015-2020)
10.13.5 Integra LifeSciences Recent Development
13.14 Organogenesis
10.14.1 Organogenesis Company Details
10.14.2 Organogenesis Business Overview
10.14.3 Organogenesis Soft Tissue Allografts Introduction
10.14.4 Organogenesis Revenue in Soft Tissue Allografts Business (2015-2020)
10.14.5 Organogenesis Recent Development
13.15 RTI Surgical
10.15.1 RTI Surgical Company Details
10.15.2 RTI Surgical Business Overview
10.15.3 RTI Surgical Soft Tissue Allografts Introduction
10.15.4 RTI Surgical Revenue in Soft Tissue Allografts Business (2015-2020)
10.15.5 RTI Surgical Recent Development
13.16 Lattice Biologics
10.16.1 Lattice Biologics Company Details
10.16.2 Lattice Biologics Business Overview
10.16.3 Lattice Biologics Soft Tissue Allografts Introduction
10.16.4 Lattice Biologics Revenue in Soft Tissue Allografts Business (2015-2020)
10.16.5 Lattice Biologics Recent Development
13.17 Globus Medical
10.17.1 Globus Medical Company Details
10.17.2 Globus Medical Business Overview
10.17.3 Globus Medical Soft Tissue Allografts Introduction
10.17.4 Globus Medical Revenue in Soft Tissue Allografts Business (2015-2020)
10.17.5 Globus Medical Recent Development
13.18 Zimmer Biomet Holdings
10.18.1 Zimmer Biomet Holdings Company Details
10.18.2 Zimmer Biomet Holdings Business Overview
10.18.3 Zimmer Biomet Holdings Soft Tissue Allografts Introduction
10.18.4 Zimmer Biomet Holdings Revenue in Soft Tissue Allografts Business (2015-2020)
10.18.5 Zimmer Biomet Holdings Recent Development
13.19 Straumann Holding
10.19.1 Straumann Holding Company Details
10.19.2 Straumann Holding Business Overview
10.19.3 Straumann Holding Soft Tissue Allografts Introduction
10.19.4 Straumann Holding Revenue in Soft Tissue Allografts Business (2015-2020)
10.19.5 Straumann Holding Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Soft Tissue Allografts Key Market Segments
Table 2. Key Players Covered: Ranking by Soft Tissue Allografts Revenue
Table 3. Ranking of Global Top Soft Tissue Allografts Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Soft Tissue Allografts Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hyaline
Table 6. Key Players of Elastic
Table 7. Key Players of Fibro
Table 8. Global Soft Tissue Allografts Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Soft Tissue Allografts Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Soft Tissue Allografts Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Soft Tissue Allografts Market Share by Regions (2015-2020)
Table 12. Global Soft Tissue Allografts Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Soft Tissue Allografts Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Soft Tissue Allografts Market Growth Strategy
Table 18. Main Points Interviewed from Key Soft Tissue Allografts Players
Table 19. Global Soft Tissue Allografts Revenue by Players (2015-2020) (Million US$)
Table 20. Global Soft Tissue Allografts Market Share by Players (2015-2020)
Table 21. Global Top Soft Tissue Allografts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Tissue Allografts as of 2019)
Table 22. Global Soft Tissue Allografts by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Soft Tissue Allografts Product Solution and Service
Table 25. Date of Enter into Soft Tissue Allografts Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 28. Global Soft Tissue Allografts Market Size Share by Type (2015-2020)
Table 29. Global Soft Tissue Allografts Revenue Market Share by Type (2021-2026)
Table 30. Global Soft Tissue Allografts Market Size Share by Application (2015-2020)
Table 31. Global Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 32. Global Soft Tissue Allografts Market Size Share by Application (2021-2026)
Table 33. North America Key Players Soft Tissue Allografts Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Soft Tissue Allografts Market Share (2019-2020)
Table 35. North America Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 36. North America Soft Tissue Allografts Market Share by Type (2015-2020)
Table 37. North America Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 38. North America Soft Tissue Allografts Market Share by Application (2015-2020)
Table 39. Europe Key Players Soft Tissue Allografts Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Soft Tissue Allografts Market Share (2019-2020)
Table 41. Europe Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Soft Tissue Allografts Market Share by Type (2015-2020)
Table 43. Europe Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Soft Tissue Allografts Market Share by Application (2015-2020)
Table 45. China Key Players Soft Tissue Allografts Revenue (2019-2020) (Million US$)
Table 46. China Key Players Soft Tissue Allografts Market Share (2019-2020)
Table 47. China Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 48. China Soft Tissue Allografts Market Share by Type (2015-2020)
Table 49. China Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 50. China Soft Tissue Allografts Market Share by Application (2015-2020)
Table 51. Japan Key Players Soft Tissue Allografts Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Soft Tissue Allografts Market Share (2019-2020)
Table 53. Japan Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Soft Tissue Allografts Market Share by Type (2015-2020)
Table 55. Japan Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Soft Tissue Allografts Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Soft Tissue Allografts Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Soft Tissue Allografts Market Share (2019-2020)
Table 59. Southeast Asia Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Soft Tissue Allografts Market Share by Type (2015-2020)
Table 61. Southeast Asia Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Soft Tissue Allografts Market Share by Application (2015-2020)
Table 63. India Key Players Soft Tissue Allografts Revenue (2019-2020) (Million US$)
Table 64. India Key Players Soft Tissue Allografts Market Share (2019-2020)
Table 65. India Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 66. India Soft Tissue Allografts Market Share by Type (2015-2020)
Table 67. India Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 68. India Soft Tissue Allografts Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Soft Tissue Allografts Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Soft Tissue Allografts Market Share (2019-2020)
Table 71. Central & South America Soft Tissue Allografts Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Soft Tissue Allografts Market Share by Type (2015-2020)
Table 73. Central & South America Soft Tissue Allografts Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Soft Tissue Allografts Market Share by Application (2015-2020)
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Product
Table 78. Allergan Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 79. Allergan Recent Development
Table 80. B. Braun Melsungen Company Details
Table 81. B. Braun Melsungen Business Overview
Table 82. B. Braun Melsungen Product
Table 83. B. Braun Melsungen Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 84. B. Braun Melsungen Recent Development
Table 85. CONMED Company Details
Table 86. CONMED Business Overview
Table 87. CONMED Product
Table 88. CONMED Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 89. CONMED Recent Development
Table 90. Xtant Medical Holdings Company Details
Table 91. Xtant Medical Holdings Business Overview
Table 92. Xtant Medical Holdings Product
Table 93. Xtant Medical Holdings Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 94. Xtant Medical Holdings Recent Development
Table 95. Alliqua BioMedical Company Details
Table 96. Alliqua BioMedical Business Overview
Table 97. Alliqua BioMedical Product
Table 98. Alliqua BioMedical Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 99. Alliqua BioMedical Recent Development
Table 100. ALON SOURCE GROUP Company Details
Table 101. ALON SOURCE GROUP Business Overview
Table 102. ALON SOURCE GROUP Product
Table 103. ALON SOURCE GROUP Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 104. ALON SOURCE GROUP Recent Development
Table 105. AlloSource Company Details
Table 106. AlloSource Business Overview
Table 107. AlloSource Product
Table 108. AlloSource Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 109. AlloSource Recent Development
Table 110. C. R. Bard Business Overview
Table 111. C. R. Bard Product
Table 112. C. R. Bard Company Details
Table 113. C. R. Bard Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 114. C. R. Bard Recent Development
Table 115. Arthrex Company Details
Table 116. Arthrex Business Overview
Table 117. Arthrex Product
Table 118. Arthrex Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 119. Arthrex Recent Development
Table 120. Bone Bank Allografts Company Details
Table 121. Bone Bank Allografts Business Overview
Table 122. Bone Bank Allografts Product
Table 123. Bone Bank Allografts Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 124. Bone Bank Allografts Recent Development
Table 125. Osiris Therapeutics Company Details
Table 126. Osiris Therapeutics Business Overview
Table 127. Osiris Therapeutics Product
Table 128. Osiris Therapeutics Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 129. Osiris Therapeutics Recent Development
Table 130. MiMedx Group Company Details
Table 131. MiMedx Group Business Overview
Table 132. MiMedx Group Product
Table 133. MiMedx Group Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 134. MiMedx Group Recent Development
Table 135. Integra LifeSciences Company Details
Table 136. Integra LifeSciences Business Overview
Table 137. Integra LifeSciences Product
Table 138. Integra LifeSciences Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 139. Integra LifeSciences Recent Development
Table 140. Organogenesis Company Details
Table 141. Organogenesis Business Overview
Table 142. Organogenesis Product
Table 143. Organogenesis Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 144. Organogenesis Recent Development
Table 145. RTI Surgical Company Details
Table 146. RTI Surgical Business Overview
Table 147. RTI Surgical Product
Table 148. RTI Surgical Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 149. RTI Surgical Recent Development
Table 150. Lattice Biologics Company Details
Table 151. Lattice Biologics Business Overview
Table 152. Lattice Biologics Product
Table 153. Lattice Biologics Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 154. Lattice Biologics Recent Development
Table 155. Globus Medical Company Details
Table 156. Globus Medical Business Overview
Table 157. Globus Medical Product
Table 158. Globus Medical Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 159. Globus Medical Recent Development
Table 160. Zimmer Biomet Holdings Company Details
Table 161. Zimmer Biomet Holdings Business Overview
Table 162. Zimmer Biomet Holdings Product
Table 163. Zimmer Biomet Holdings Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 164. Zimmer Biomet Holdings Recent Development
Table 165. Straumann Holding Company Details
Table 166. Straumann Holding Business Overview
Table 167. Straumann Holding Product
Table 168. Straumann Holding Revenue in Soft Tissue Allografts Business (2015-2020) (Million US$)
Table 169. Straumann Holding Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Soft Tissue Allografts Market Share by Type: 2020 VS 2026
Figure 2. Hyaline Features
Figure 3. Elastic Features
Figure 4. Fibro Features
Figure 5. Global Soft Tissue Allografts Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Dental Clinics Case Studies
Figure 9. Soft Tissue Allografts Report Years Considered
Figure 10. Global Soft Tissue Allografts Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Soft Tissue Allografts Market Share by Regions: 2020 VS 2026
Figure 12. Global Soft Tissue Allografts Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Soft Tissue Allografts Market Share by Players in 2019
Figure 15. Global Top Soft Tissue Allografts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Tissue Allografts as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Soft Tissue Allografts Revenue in 2019
Figure 17. North America Soft Tissue Allografts Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Soft Tissue Allografts Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Soft Tissue Allografts Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Soft Tissue Allografts Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Soft Tissue Allografts Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Soft Tissue Allografts Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Soft Tissue Allografts Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
整形外科用軟組織修復の世界市場（～2026年） Soft tissue includes tendons, ligaments, fascia, skin, fibrous tissues, fat, and synovial membranes (which are connective tissue), and muscles, nerves and blood vessels (which are not connective tissue). The primary growth factor is sport injuries, which is estimated to contribute to a great extent …- 心血管・軟部組織修復パッチの世界市場（～2026年） Cardiovascular and soft tissue are manufactured by ePTFE and biomaterial. Owing to the increasing prevalence of congenital heart diseases such as ventricular septal defect, atrial septal defect and common atrium, the cardiovascular and soft tissue repair patches market is expected to grow rapidly ov…
- 軟部肉腫治療の世界市場（～2026年） Sarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Increasing cases of soft tissue sarcoma and different types of cancer are expected to boost the growth for soft tissue sarcoma market. Market Analysis and Insights: Global So…
- 軟組織強化・再生の世界市場（～2026年） Soft tissue reinforcement treatment involves harvesting a small piece of soft tissue from other part of the body and placing it in the place of damaged soft tissue in order to support it. Rising disposable income, awareness about tissue regeneration and reinforcement treatments and increasing succes…
- 同種異系移植の世界市場（～2026年） Market Analysis and Insights: Global Allografts Market The global Allografts market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant att…